These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1848576)
21. Induction of the p53-target gene GADD45 in HPV-positive cancer cells. Butz K; Whitaker N; Denk C; Ullmann A; Geisen C; Hoppe-Seyler F Oncogene; 1999 Apr; 18(14):2381-6. PubMed ID: 10327059 [TBL] [Abstract][Full Text] [Related]
22. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene. Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692 [TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus E7 proteins stimulate proliferation independently of their ability to associate with retinoblastoma protein. Caldeira S; de Villiers EM; Tommasino M Oncogene; 2000 Feb; 19(6):821-6. PubMed ID: 10698500 [TBL] [Abstract][Full Text] [Related]
24. The expression levels of the human papillomavirus type 16 E7 correlate with its transforming potential. Liu Z; Ghai J; Ostrow RS; Faras AJ Virology; 1995 Feb; 207(1):260-70. PubMed ID: 7871737 [TBL] [Abstract][Full Text] [Related]
25. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells. Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029 [TBL] [Abstract][Full Text] [Related]
26. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53. Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502 [TBL] [Abstract][Full Text] [Related]
27. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Banks L; Edmonds C; Vousden KH Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461 [TBL] [Abstract][Full Text] [Related]
28. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein. Brokaw JL; Yee CL; Münger K Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265 [TBL] [Abstract][Full Text] [Related]
29. Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA. DiPaolo JA; Popescu NC; Alvarez L; Woodworth CD Crit Rev Oncog; 1993; 4(4):337-60. PubMed ID: 8394744 [TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 E6 and E7 proteins inhibit differentiation-dependent expression of transforming growth factor-beta2 in cervical keratinocytes. Nees M; Geoghegan JM; Munson P; Prabhu V; Liu Y; Androphy E; Woodworth CD Cancer Res; 2000 Aug; 60(15):4289-98. PubMed ID: 10945644 [TBL] [Abstract][Full Text] [Related]
31. Mutational analysis of HPV-18 E6 identifies domains required for p53 degradation in vitro, abolition of p53 transactivation in vivo and immortalisation of primary BMK cells. Pim D; Storey A; Thomas M; Massimi P; Banks L Oncogene; 1994 Jul; 9(7):1869-76. PubMed ID: 8208532 [TBL] [Abstract][Full Text] [Related]
32. Immunological responses in human papillomavirus 16 E6/E7-transgenic mice to E7 protein correlate with the presence of skin disease. Frazer IH; Leippe DM; Dunn LA; Liem A; Tindle RW; Fernando GJ; Phelps WC; Lambert PF Cancer Res; 1995 Jun; 55(12):2635-9. PubMed ID: 7540107 [TBL] [Abstract][Full Text] [Related]
33. The E7 open reading frame of human papillomavirus type 16 encodes a transforming gene. Vousden KH; Doniger J; DiPaolo JA; Lowy DR Oncogene Res; 1988 Sep; 3(2):167-75. PubMed ID: 2852339 [TBL] [Abstract][Full Text] [Related]
34. SOCS1 [corrected] inhibits HPV-E7-mediated transformation by inducing degradation of E7 protein. Kamio M; Yoshida T; Ogata H; Douchi T; Nagata Y; Inoue M; Hasegawa M; Yonemitsu Y; Yoshimura A Oncogene; 2004 Apr; 23(17):3107-15. PubMed ID: 15021916 [TBL] [Abstract][Full Text] [Related]
35. Destabilization of the RB tumor suppressor protein and stabilization of p53 contribute to HPV type 16 E7-induced apoptosis. Jones DL; Thompson DA; Münger K Virology; 1997 Dec; 239(1):97-107. PubMed ID: 9426450 [TBL] [Abstract][Full Text] [Related]
36. Improved immunodetection of human papillomavirus E7. Jeon JH; Cho SY; Kim CW; Shin DM; Kwon JC; Choi KH; Kim IG Exp Mol Med; 2002 Dec; 34(6):496-9. PubMed ID: 12526093 [TBL] [Abstract][Full Text] [Related]
37. Oncogenicity of human papillomavirus- or adenovirus-transformed cells correlates with resistance to lysis by natural killer cells. Routes JM; Ryan S J Virol; 1995 Dec; 69(12):7639-47. PubMed ID: 7494272 [TBL] [Abstract][Full Text] [Related]
38. Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins. Sang BC; Barbosa MS Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8063-7. PubMed ID: 1325643 [TBL] [Abstract][Full Text] [Related]
39. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product. Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832 [TBL] [Abstract][Full Text] [Related]
40. Efficiency of binding the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Heck DV; Yee CL; Howley PM; Münger K Proc Natl Acad Sci U S A; 1992 May; 89(10):4442-6. PubMed ID: 1316608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]